Simplivia at 3rd Israeli Oncology Pharmacists Conference

Simplivia highlighted its leading Chemfort™ CSTD at the 2022 Israeli Oncology Pharmacists Conference.
March 05, 2022

Simplivia™’s Chemfort™ in Focus

Simplivia recently participated in the 3rd Israeli Oncology Pharmacists Conference, held on March 3rd, 2022 in Herzlia, Israel. The conference was attended by over 60 pharmacists, who participated in a full day of seminars and exhibitions related to oncology pharmacy in Israel.

At the conference, Simplivia presented its Chemfort™ closed system drug-transfer device product family. Chemfort™ reduces the risk of exposure to hazardous drugs, and provides oncology pharmacists with safety and confidence when handling hazardous drugs. For additional information, see our article on Top Trends in Oncology Pharmacy Today.